Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  22,253 نتائج ل ""ritonavir""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia.

  • Authors : Low EV; Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, No.1 Jalan Setia Murni U13/52, Seksyen U13, Shah Alam, Selangor, 40170, Malaysia. .; Institute for Health Systems Research, National Institutes of Health, Ministry of Health Malaysia, No.1 Jalan Setia Murni U13/52, Seksyen U13, Shah Alam, Selangor, 40170, Malaysia. .

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Quality of Life* ; COVID-19 Drug Treatment*

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 05; Vol. 24 (1), pp. 780. Date of Electronic Publication: 2024 Aug 05.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis.

  • Authors : Okoli GN; George and Fay Yee Centre for Healthcare Innovation, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada .; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; COVID-19 Drug Treatment* ; SARS-CoV-2*

  • Source: Annals of family medicine [Ann Fam Med] 2024 Jul-Aug; Vol. 22 (4), pp. 336-346.Publisher: Annals of Family Medicine, Inc Country of Publication: United States NLM ID: 101167762 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.

  • Authors : Butt AA; VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America.; Weill Cornell Medicine, New York, New York, United States of America.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Hydroxylamines*/Hydroxylamines*/Hydroxylamines*/therapeutic use ; Disease Progression*

  • Source: PloS one [PLoS One] 2024 Jun 06; Vol. 19 (6), pp. e0298254. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
  • 1-10 ل  22,253 نتائج ل ""ritonavir""